#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatoblastoma Cardiac sarcoidosis Lymphangioma High-grade B-cell lymphoma Glomerulonephritis membranous Von Hippel-Lindau disease Leiomyosarcoma metastatic Lennox-Gastaut syndrome Transient ischaemic attack Scedosporium infection Thrombocytosis Juvenile chronic myelomonocytic leukaemia Osteogenesis imperfecta Dementia Piriformis syndrome More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Treatment Alagille syndrome – Life with Disease Rhabdomyosarcoma recurrent – Diagnostics Idiopathic pulmonary fibrosis – Life with Disease Breast angiosarcoma metastatic – Treatment Hereditary optic atrophy – Treatment Toxic epidermal necrolysis – Trials in Disease Angelman’s syndrome – Diagnostics Pelizaeus-Merzbacher disease – Treatment Activated PI3 kinase delta syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VELPATASVIR Epinephrine Hydrochloride Adalimumab Modafinil Messenger Rna Encoding Cas9 Iph5201 Ciclesonide Milnacipran Hydrochloride Mirodenafil Dihydrochloride H2-Receptor Antagonist Bulevirtide Prednisolone Incb000928 GSKVX000000034797 Ceftolozane Sodium Lactate Zidovudine Pitolisant Anhydrous Caffeine Paeonol More therapies…

    Learn about Your Condition

    Vasospasm Onychomycosis Ejection fraction normal Neurofibrosarcoma Transferrin decreased Mantle cell lymphoma stage III Cholangiocarcinoma Postoperative wound infection Angiosarcoma Turner's syndrome Hypereosinophilic syndrome Testicular leiomyosarcoma Herpes zoster Sarcoma metastatic Short-bowel syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Relapsing multiple sclerosis

  • Study on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • (R)-1-(Tert-Butyl)-N-(8-(2-((1-Methyl-1H-Pyrazol-4-Yl)Amino)Pyrimidin-4-Yl)-2-(Oxetan-3-Yl)-2,3,4,5-Tetrahydro-1H-Benzo[C]Azepin-5-Yl)-1H-1,2,3-Triazole-4-Carboxamide
    • Diroximel Fumarate
    • Gadoteric Acid
    Bulgaria Czechia Germany Italy Poland Romania +1

  • Study on the Effectiveness of Vidofludimus Calcium (IMU-838) in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Drugs:
    • Vidofludimus Calcium
    Bulgaria Germany Lithuania Poland

  • Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Ublituximab
    Croatia Poland
Previous Page
1 2 3 4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!